|
Biomarin Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
The Medicines Company Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Pharmacogenomics Partnering Terms and Agreements 2010 to 2017 |
Sep 1 2017 |
129 |
Global |
$2,995.00 |
|
|
Global Human Papilloma Virus Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Hospira Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Migraine Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Alnylam Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Smoking Cessation Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Regeneron Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Transplantation Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Eisai Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Cervical Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Dermatology Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
500 |
Global |
$2,995.00 |
|
|
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Ophthalmics Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
500 |
Global |
$2,995.00 |
|
|
Global Musculoskeletal Symptoms Partnering 2010-2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Monsanto Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Gastrointestinal Symptoms Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
BioCryst Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Targacept Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2017 |
Sep 1 2017 |
330 |
Global |
$2,995.00 |
|
|
Global Clostridium difficile Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Multiple Sclerosis Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Alkermes Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Obesity Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Questcor Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Accident & Emergency Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Dainippon Sumitomo Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Academic and Non-Profit Partnering Terms and Agreements 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
1000 |
Global |
$2,995.00 |
|
